APA (7th ed.) Citation

M, B., EL, L., I, J., MS, T., CM, L., L, R., . . . BV, O. (2018). The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: Results from the DBCG HYPO trial. Acta oncologica (Stockholm, Sweden), 57(1), 113. https://doi.org/10.1080/0284186X.2017.1406139

Chicago Style (17th ed.) Citation

M, Berg, Lorenzen EL, Jensen I, Thomsen MS, Lutz CM, Refsgaard L, Nissen HD, and Offersen BV. "The Potential Benefits from Respiratory Gating for Breast Cancer Patients Regarding Target Coverage and Dose to Organs at Risk When Applying Strict Dose Limits to the Heart: Results from the DBCG HYPO Trial." Acta Oncologica (Stockholm, Sweden) 57, no. 1 (2018): 113. https://doi.org/10.1080/0284186X.2017.1406139.

MLA (9th ed.) Citation

M, Berg, et al. "The Potential Benefits from Respiratory Gating for Breast Cancer Patients Regarding Target Coverage and Dose to Organs at Risk When Applying Strict Dose Limits to the Heart: Results from the DBCG HYPO Trial." Acta Oncologica (Stockholm, Sweden), vol. 57, no. 1, 2018, p. 113, https://doi.org/10.1080/0284186X.2017.1406139.